EdgarLookup

LIGAND PHARMACEUTICALS INC — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 144/A 15-12G 3 3/A 4 4/A 424B1 424B3 424B5 425 5 8-A12B 8-A12G 8-A12G/A 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFM14A DEFN14A DFAN14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A PREN14A PRER14A S-1 S-1/A S-3 S-3/A S-3ASR S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13E3 SC 13E3/A SC 13E4 SC 13E4/A SC 13G SC 13G/A SC TO-C SC TO-T SC TO-T/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
144 0001969223-25-000815 Oct 1, 2025
4 PRIMARY DOCUMENT 0002001011-25-000081 Sep 24, 2025 Sep 22, 2025
4 PRIMARY DOCUMENT 0002001011-25-000082 Sep 24, 2025 Sep 23, 2025
144 0001950047-25-007467 Sep 23, 2025
144 0001949846-25-000485 Sep 17, 2025
8-K 8-K 0001193125-25-205147 Sep 16, 2025 Sep 12, 2025
4 PRIMARY DOCUMENT 0002001011-25-000068 Sep 4, 2025 Sep 2, 2025
144 0001969223-25-000704 Sep 2, 2025
8-K 8-K 0001193125-25-180841 Aug 14, 2025 Aug 11, 2025
SCHEDULE 13G/A 0001274173-25-000241 Aug 14, 2025
4 PRIMARY DOCUMENT 0002001011-25-000061 Aug 12, 2025 Aug 10, 2025
8-K 8-K 0001193125-25-177452 Aug 11, 2025
10-Q 10-Q 0000886163-25-000051 Aug 8, 2025 Jun 30, 2025
8-K 8-K 0000886163-25-000047 Aug 7, 2025
4 PRIMARY DOCUMENT 0002001011-25-000059 Aug 5, 2025 Aug 1, 2025
144 0001969223-25-000548 Aug 1, 2025
4 PRIMARY DOCUMENT 0002001011-25-000053 Jul 11, 2025 Jul 10, 2025
144 0001969223-25-000503 Jul 10, 2025
4 4 0000950170-25-093589 Jul 3, 2025 Jul 1, 2025
3 3 0000950170-25-093585 Jul 3, 2025 Jul 1, 2025
SCHEDULE 13D 0000950170-25-093838 Jul 3, 2025
4 PRIMARY DOCUMENT 0002001011-25-000050 Jul 2, 2025 Jun 30, 2025
4 PRIMARY DOCUMENT 0002001011-25-000051 Jul 2, 2025 Jun 30, 2025
8-K 8-K 0000886163-25-000042 Jul 2, 2025
4 PRIMARY DOCUMENT 0002001011-25-000052 Jul 2, 2025 Jun 30, 2025
3/A PRIMARY DOCUMENT 0002001011-25-000049 Jul 2, 2025 Nov 1, 2022
4 PRIMARY DOCUMENT 0002001011-25-000048 Jun 24, 2025 Jun 23, 2025
144 0001950047-25-004546 Jun 23, 2025
4 PRIMARY DOCUMENT 0002001011-25-000047 Jun 12, 2025 Jun 10, 2025
4 PRIMARY DOCUMENT 0002001011-25-000046 Jun 10, 2025 Jun 6, 2025
144 0001950047-25-004123 Jun 10, 2025
4 PRIMARY DOCUMENT 0002001011-25-000040 Jun 10, 2025 Jun 6, 2025
4 PRIMARY DOCUMENT 0002001011-25-000041 Jun 10, 2025 Jun 6, 2025
4 PRIMARY DOCUMENT 0002001011-25-000042 Jun 10, 2025 Jun 6, 2025
4 PRIMARY DOCUMENT 0002001011-25-000043 Jun 10, 2025 Jun 6, 2025
4 PRIMARY DOCUMENT 0002001011-25-000044 Jun 10, 2025 Jun 6, 2025
4 PRIMARY DOCUMENT 0002001011-25-000045 Jun 10, 2025 Jun 6, 2025
8-K 8-K 0000886163-25-000040 Jun 9, 2025
4 PRIMARY DOCUMENT 0002001011-25-000037 Jun 2, 2025 Aug 10, 2024
4 PRIMARY DOCUMENT 0002001011-25-000036 Jun 2, 2025 Jan 17, 2025
144 0001950047-25-003094 May 15, 2025
SCHEDULE 13G/A 0001274173-25-000165 May 14, 2025
4 PRIMARY DOCUMENT 0002001011-25-000028 May 13, 2025 May 9, 2025
4 PRIMARY DOCUMENT 0002001011-25-000029 May 13, 2025 May 9, 2025
10-Q 10-Q 0000886163-25-000036 May 9, 2025 Mar 31, 2025
8-K 8-K 0000886163-25-000033 May 8, 2025
DEFA14A DEFA14A 0000886163-25-000027 Apr 22, 2025
ARS ARS 0000886163-25-000029 Apr 22, 2025 Dec 31, 2024
DEF 14A DEF 14A 0000886163-25-000025 Apr 22, 2025 Dec 31, 2024
8-K 8-K 0000886163-25-000020 Apr 17, 2025 Apr 16, 2025